Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38157 POSTS 0 COMMENTS
The number of U.S. breast cancer patients choosing to have a healthy breast removed has tripled in the past decade

Preventive Mastectomies Triple for U.S. Women Over Past Decade

0
Patients increasingly opt to have the healthy breast removed, despite limited benefit
For patients with chronic calcific pancreatitis

Antioxidant-Pregabalin Cuts Pain in Chronic Calcific Pancreatitis

0
Randomized trial shows significant pain reduction for patients with chronic calcific pancreatitis
For obese youth

HIIT May Be Most Effective Exercise Method for Obese Youth

0
May be more effective than other types of exercise for improving blood pressure, aerobic capacity levels
Trends indicate a reduction in glyburide and thiazolidinedione prescriptions and increases in gliclazide and dipeptidyl peptidase-4 inhibitor prescriptions among older adults with diabetes and chronic kidney disease

Antihyperglycemic Medication Prescribing Trends Are Changing

0
Decrease in glyburide and thiazolidinedione Rx; increase in gliclazide, dipeptidyl peptidase-4 inhibitor
U.S. primary care practices use less than one care management process for depression

Few Care Management Processes Used for Depression

0
Primary care practices use less than one care management process for depression, on average
Elective early-term deliveries may not be associated with increased risk of adverse neonatal outcomes

Early-Term Delivery May Not Up Adverse Neonatal Outcomes

0
Those delivered after elective induction at 37 to 38 weeks don't have increased sepsis, NICU admission
Electronic consultation

E-Consultations Can Improve Access to, Timeliness of Care

0
Median days to a review for an e-consultation was five days, versus 24 days for traditional visit
Clinician communication and prescribing behavior reinforce parents' understanding of antibiotic treatment

Doctor Communication Supports Parents’ Beliefs About Antibiotics

0
Antibiotic prescriptions confirm parents' beliefs about what indicates illness severity
Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer with tumors that have a rare ROS1 gene mutation.

FDA Approves Xalkori for Rare Genetic Form of Lung Cancer

0
Drug approval expanded to include patients with ROS1-positive NSCLC
The 21-gene recurrence score (Oncotype DX) seems to accurately identify women with early-stage breast cancer who don't need chemotherapy

Gene Test IDs Breast CA Patients Who May Not Need Chemo

0
Analysis can help women who won't benefit from additional treatment to avoid side effects